ABN AMRO Fund

ABN AMRO&s;s investment arm makes investments in early-, mid-, and late-stage companies around the world

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed ABN AMRO Fund Information

Geographic Data

ABN AMRO Fund headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

6,962Website Global Rank

18,247,890Website Monthly Traffic

Twitter Followers

Description

ABN AMRO serves retail, private and commercial banking customers in the Netherlands and across the globe. Along with a comprehensive range of products and services, we offer in-depth financial expertise, extensive knowledge of numerous sectors and an international network supporting our customers’ domestic and international operations. We aim to respond to the ever-changing market and, in doing so, to our customers’ ever-changing needs. Customers want a bank that acts in the context of today’s realities and is straightforward with them at all times; a bank that learns from its experiences and whose top priority is to provide the best possible service.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
2/2002 AM Pharma Series B -
11/2007 BioVex Series E 35M
10/2003 BioVex Series C 28.4M
2/2000 clickNsettle.com Venture Round 8.8M
5/2018 Exasun Venture Round -
3/2022 In Ovo Series B 0
9/2002 BEELINE Technologies Venture Round 11.2M
5/2021 Envision Seed Round 0
6/2000 Aucxis Corporation Venture Round 7.5M
12/2004 CircuLite Series A 7M
8/2000 EcomXML Venture Round 0
3/2000 BeXcom Venture Round 75M
7/2001 UpShot Corporation Series E 17M
12/2018 Fairphone Debt Financing 14.7M
7/2005 Xention Series B 13.3M
10/2001 Ardana Bioscience Series A 20M
1/2004 Accelerated Technologies Series B 32M
12/1999 Cortera Venture Round 0
2/2008 Evenementenhal Hardenberg Venture Round -
3/2005 Alantos Pharmaceuticals Series B 0
9/2022 Exasun Venture Round 0
5/2003 Acorda Therapeutics Series B 55.3M
11/2000 Pluris Series D 0
8/2000 BondDesk Venture Round -
4/2004 Cilian AG Series B 6.1M
10/1999 Drug Abuse Sciences Venture Round 22.4M
3/2003 Acadia Pharmaceuticals Inc. Series F 25M
4/2000 Cycore Venture Round 10M
3/2006 PanGenetics Series B 15.6M
4/2000 Telenisus Series B 50M
7/2003 Ardana Bioscience Series B 32.4M
2/2000 Corechange Inc Series B 0
10/2004 Bluebird Bio Venture Round 12M
6/2004 Bluebird Bio Series A 8.5M
5/2007 SPS Commerce Venture Round 7.5M
10/2004 FlowMedica Series C 0
11/2002 SPS Commerce Venture Round -
3/2000 IMX Exchange Venture Round 15.7M
1/2003 Impella Cardiosystems Venture Round 40M
10/2001 Mysticom Venture Round 28M
1/2023 Seepje Venture Round 4.6M
6/2000 LNG Holdings Private Equity Round 1.1B
10/2002 Pieris AG Series A 0
3/2001 Drug Abuse Sciences Series A 46.5M
5/2015 Barge Master Private Equity Round -
11/2019 Picnic Debt Financing 55M
12/2016 Goodnight Midstream Debt Financing 0
1/2011 Ensartech Venture Round -
6/2000 Xpede Series B 0
1/2000 Integral Development Corp Private Equity Round 40M
3/2016 TradeBridge Debt Financing 69.8M
8/2000 Tradiant Venture Round 0
3/2022 In Ovo Series B 0
5/2021 Envision Seed Round 0
11/2019 Picnic Debt Financing 0
12/2018 Fairphone Debt Financing 0
5/2018 Exasun Venture Round -
12/2016 Goodnight Midstream Debt Financing 0
3/2016 TradeBridge Debt Financing 0
2/2016 Digital Asset Venture Round 0
5/2015 Barge Master Private Equity Round -
1/2011 Ensartech Venture Round -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.